Page last updated: 2024-08-22

metomidate and fluorodeoxyglucose f18

metomidate has been researched along with fluorodeoxyglucose f18 in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Friberg, J; Långsjö, J; Minn, H; Någren, K; Nuutila, P; Roivainen, A; Salmi, J; Salonen, A; Välimäki, M; Viljanen, T	1
Becherer, A; Dudczak, R; Kletter, K; Mitterhauser, M; Niederle, B; Pirich, C; Vierhapper, H; Wadsak, W; Zettinig, G	1
Karges, W; Mottaghy, FM; Van Binnebeek, S	1
Chang, CC; Chen, CJ; Chueh, JS; Lu, CC; Peng, KY; Wu, VC; Yen, RF	1

Trials

2 trial(s) available for metomidate and fluorodeoxyglucose f18

Article	Year
Imaging of adrenal incidentalomas with PET using (11)C-metomidate and (18)F-FDG. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2004, Volume: 45, Issue:6 Topics: Adrenal Gland Neoplasms; Adult; Aged; Carbon Radioisotopes; Etomidate; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Metabolic Clearance Rate; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed	2004
Positron emission tomography imaging of adrenal masses: (18)F-fluorodeoxyglucose and the 11beta-hydroxylase tracer (11)C-metomidate. European journal of nuclear medicine and molecular imaging, 2004, Volume: 31, Issue:9 Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Carbon Radioisotopes; Etomidate; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Steroid 11-beta-Hydroxylase; Tissue Distribution	2004

Article

Year

Imaging of adrenal incidentalomas with PET using (11)C-metomidate and (18)F-FDG.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2004, Volume: 45, Issue:6

Topics: Adrenal Gland Neoplasms; Adult; Aged; Carbon Radioisotopes; Etomidate; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Metabolic Clearance Rate; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed

2004

Positron emission tomography imaging of adrenal masses: (18)F-fluorodeoxyglucose and the 11beta-hydroxylase tracer (11)C-metomidate.

European journal of nuclear medicine and molecular imaging, 2004, Volume: 31, Issue:9

Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Carbon Radioisotopes; Etomidate; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Steroid 11-beta-Hydroxylase; Tissue Distribution

2004

Other Studies

2 other study(ies) available for metomidate and fluorodeoxyglucose f18

Article	Year
Functional imaging of neuroendocrine tumors. Methods in molecular biology (Clifton, N.J.), 2011, Volume: 727 Topics: 5-Hydroxytryptophan; Animals; Contrast Media; Dihydroxyphenylalanine; Dopamine; Ephedrine; Etomidate; Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Peptides; Positron-Emission Tomography; Radioactive Tracers; Radiopharmaceuticals; Somatostatin	2011
Predicting Treatment Response in Primary Aldosteronism Using 11 C-Metomidate Positron Emission Tomography. Clinical nuclear medicine, 2022, Nov-01, Volume: 47, Issue:11 Topics: Adosterol; Etomidate; Fluorodeoxyglucose F18; Humans; Hyperaldosteronism; Positron-Emission Tomography; Prospective Studies	2022